# IRulya Therapeutics Inc.: Form 8-K, filed Jun 26, 2026

- Company: [IRulya Therapeutics Inc.](/companies/irla.md) (CIK 1662774)
- Form: 8-K
- Filed: 2026-06-26
- Accepted by EDGAR: Jun 26, 2026, 09:18 ET
- Period: 2026-06-26
- Accession: 0001193125-26-284089
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662774/000119312526284089/d168420d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662774/000119312526284089/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662774/000119312526284089/d168420d8k.htm

Filed Jun 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-284089. Last ingested by Listed: Nov 5, 2026, 16:02 ET. No prices; not investment advice.